New ovarian cancer chemotherapy

As early ovarian tumor spread, surgery is not clear when the majority of cases lesions, and the effects of radiotherapy and its application is very limited, systemic chemotherapy is an important adjuvant therapy. Some patients with advanced, mass can be reduced after chemotherapy, surgery to re-create the favorable conditions.
Based on years of clinically proven principles of the latest chemotherapy of ovarian cancer are:
smaller doses of high dose continuous treatment of intermittent treatment is better; the former refers to each course of treatment about 1 week, 3 to 4 weeks of intermittent, can achieve effective anti-tumor effect, and it helps the body to eliminate toxicity and restore immune function.
chemotherapy better than single chemotherapy: combination of modern multi-trend, but the toxicity of combination chemotherapy should be noted that heavy.
According to the drug sensitivity test, sensitive to the chemotherapy drugs used to extend the survival time of patients.
by tissue type for different chemotherapy regimens. Commonly used chemotherapy of ovarian cancer in recent years are as follows.
Here are two new ovarian cancer chemotherapy:
New ovarian cancer chemotherapy (1) epithelial carcinoma and sex cord stromal tumors with
PAC Programme: CTX 400mg intravenous injection of the first day, ADM40mg intravenous injection of the next day, DDP80mg intraperitoneal injection of the third day.
CFP program: CTX 400mg intravenous injection of the first day, 5FUl50mg intraperitoneal injection intraperitoneal injection of DDP 80mg next day, the third day.
CP program: CXR 200mg intravenous infusion for 5 days DDP 40mg intravenously for 5 days.
CHFP program: 5FUl000mg intravenous infusion on day 1 or day 8, DDP 40mg intravenously on day 1, the first 8 days of oral CTX l00mg sequence 2 day 7 days 2 and 9 to 16 days.
New ovarian cancer chemotherapy (2) germ cell tumor and sarcoma multi-
VAC program: VCR 2mg intravenous infusion of l-day, ACD 300ug intravenous 2 to 6 days, CTX 300mg intravenous infusion of 2 to 6 days
FAC program: 5Fulooomg intravenous infusion for 5 days, ACD 300ug intravenous infusion for 5 days CTX 300mg intravenous injection for 5 days.
PVB solution: VLB20mg (or VCR2mg) injected on day 1, BLM30mg muscle or intraperitoneal injection of 2 days, DDP20 ~ 30mg intravenous drip or intraperitoneal injection of 1 to 5 days.
Each of the above programs the general interval of 3-4 weeks of treatment, patients should be considered physical situation, the degree of response, blood and liver and renal function conditions. Medication at least 4 to 6 courses, advanced or were not sensitive to chemotherapy, treatment should be more generally the first 1 year and 8 to 10 cycles, a decrease of 2 to 3 to 4 courses.